Corbus Pharmaceuticals presented Phase 1 data on CRB-701 at ASCO GU, showing safety, tolerability, and responses across multiple tumor types.

A new University of Kentucky Markey Cancer Center study provides important insights for future clinical trials in treating ...

Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...

Results from the PEACOCC trial warrant further investigation into treatment with pembrolizumab in patients with previously ...

Chemoradiation with platinum-based chemo is standard for locally advanced cervical cancer, but adverse events drive ...

Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...

Here are 5 important questions to ask if you’ve been told you have cervical dysplasia: ...

The Action Plan for Accelerating Elimination of Cervical Cancer (2023-2030) was put forward by the National Health Commission of China in 2023, and several cities with high health resources have ...

SAGINAW, Mich. (WJRT) - As we round out the month of January, it's important to recognize Cervical cancer Awareness Month. The American Cancer Society estimates that this year, over 13,000 new ...

Cervical cancer, the fourth most common cancer in women, is closely linked to persistent HPV infections. Early detection through Pap smears and HPV testing can significantly reduce mortality.

An investigational therapeutic vaccine showed clinical effectiveness in patients with human papillomavirus (HPV)16-positive cervical intraepithelial neoplasia grade 3 (CIN3), according to results from ...

Get Instant Summarized Text (Gist) A therapeutic vaccine targeting HPV16 showed promise in reducing high-grade precancerous cervical lesions in a Phase II clinical trial. Among 18 patients with ...